Peer-influenced content. Sources you trust. No registration required. This is HCN.


Oncology News Central (ONC)

Five Deaths in Prostate Cancer Trial Send MacroGenics’ Stock Plummeting

Oncology, Medical June 4th 2024

Oncology News Central (ONC)

Trastuzumab Deruxtecan Granted Accelerated Approval for HER2-Positive Solid Tumors

Oncology, Medical May 13th 2024

Clinical Advances in Hematology & Oncology

Highlights in Metastatic Breast Cancer From the 2023 San Antonio Breast Cancer Symposium

Oncology, Medical March 11th 2024

Oncology News Central (ONC)

New Frontline Standard for Urothelial Carcinoma Comes With Questions

Oncology, Medical August 28th 2023

Prova Education

Contextualizing the Evidence in Lymphomas: ADCs and Bispecific Antibodies in HL, FL, and DLBCL (CME)

Hematology/Oncology July 10th 2023


Where do Anti-TROP2 ADCs Factor into Advanced TNBC Care?

Oncology, Medical June 8th 2023

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form